期刊文献+

术中快速冰冻切片与术后石蜡切片用于卵巢肿瘤诊断中的应用价值比较 被引量:3

Comparison of intraoperative frozen section and postoperative paraffin section in the diagnosis of ovarian cancer
原文传递
导出
摘要 目的探讨术中快速冰冻切片与术后石蜡切片用于卵巢肿瘤诊断中的应用价值。方法选定本院2018年7月-2020年10月收诊的114例卵巢肿瘤患者,按照诊断方法不同分为观察组(术中快速冰冻切片)与对照组(术后石蜡切片),其中对照组为金标准。观察两组的检查时间,并分析比较其误诊率、延迟诊断率及完全符合率。结果①观察组的检查时间(35.62±5.14)min,短于对照组的(183.93±9.82)min(P<0.05)。②相较于对照组,观察组的误诊率为3.51%(4/114),延迟诊断率为0.88%(1/114),完全符合率为95.61%(109/114)。其中误诊1例性索间质肿瘤、2例上皮源性肿瘤、1例生殖细胞肿瘤,并延迟诊断1例生殖细胞肿瘤。结论术中快速冰冻切片有助于缩短卵巢肿瘤患者的诊断时间,且其诊断准确率较高,整体诊断价值良好。
作者 孙志明
出处 《首都食品与医药》 2021年第19期44-45,共2页 Capital Food Medicine
  • 相关文献

参考文献8

二级参考文献68

  • 1李巍,崔恒,冯捷,李艺.卵巢癌诊断的研究进展[J].中华妇产科杂志,2005,40(7):496-498. 被引量:74
  • 2阳志军,杨光,蒋燕明,冉宇靓,杨治华,张玮,张洁清,潘忠勉,李力.卵巢上皮性癌相关抗原的筛选和血清学检测[J].中华妇产科杂志,2007,42(12):834-839. 被引量:19
  • 3Siegel R, Na/shadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin,2012, 62( 1 ) :10-29.
  • 4JacobsI J, Menon U. Progress and challenges in screening for early detection of ovarian Cancer. Mlo Cell Proteomics, 2004, 3 ( 4 ) : 355-366.
  • 5Escudero J M, Auge J M, Fi|ella X, et al. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant dieases. Clin Chem,2011,57( 11 ) :1534-1544.
  • 6Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis- specific cDNA encodes a protein with sequencehomology to extracellular proteinase inhibitors. Biol Reprod, 1991, 45 ( 2 ) : 350-357.
  • 7Moore R G, Brown A K,Miller M C ,et al. The use of multiplenovel Tumor biomarkers for the detection of ovarian carcinoma in patients With a pelvic mass. Gynecol Oncol,2008,108 (2) :402-408.
  • 8Hellstmm I, Rayeraft J, Hayden-Ledbetter M, et al. The HE4 ( WFDC2 ) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003,63 ( 13 ) :3695-3700.
  • 9UrbanN, Thorpe J, Karlan B Y, et al. Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer. Cancer Epidemiol Biomarkers Prey,2012,21 ( 11 ) : 2087-2094.
  • 10. MolinaR, Escndero J M, Auge J M, et al. HE4 a novel tumour marker for ovarian cancer:comparison with CA125 and ROMA algorithm in patients with gynaecological diseases. Turnout Biol, 2011,32 ( 6 ) : 1087-1095.

共引文献106

同被引文献34

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部